ALMIRALL SA (LBTSF:OTCMKTS)
$0 None (None%)
Analysed ALMIRALL SA (LBTSF:OTCMKTS) News Sources
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
19-02-2026
yahoo.com
Almirall SA (LBTSF) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Investments
23-02-2026
yahoo.com
Almirall SA (STU:E2Z) Q2 2026 Earnings Call Highlights: Strong Growth in Dermatology and ...
24-07-2026
yahoo.com
Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology
10-08-2026
yahoo.com
Non-Melanoma Skin Cancer Market: Focus on Disease Indication, Treatment Type, Country and Region, 2025-2035
31-08-2026
yahoo.com
Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026
30-09-2026
yahoo.com
EADV 2026: Long-Term Disease Control for up to Five Years in Patients With Moderate-to-Severe Atopic Dermatitis Treated With Lebrikizumab
01-10-2026
yahoo.com
Is Almirall (BME:ALM) A Bargain As Lebrikizumab Data Strengthens Its Valuation Case?
10-10-2026
yahoo.com
What is the current price of ALMIRALL SA (LBTSF:OTCMKTS)?
The current price of ALMIRALL SA (LBTSF:OTCMKTS) is $0.
ALMIRALL SA (LBTSF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ALMIRALL SA (LBTSF:OTCMKTS) since the previous trading day is $None.
ALMIRALL SA (LBTSF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ALMIRALL SA (LBTSF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for ALMIRALL SA (LBTSF:OTCMKTS)?
The most recent average sentiment score for ALMIRALL SA (LBTSF:OTCMKTS) is 81 out of 100.
What is the most recent average sentiment for ALMIRALL SA (LBTSF:OTCMKTS)?
The most recent sentiment for ALMIRALL SA (LBTSF:OTCMKTS) is .
SEC-8K** Filing Available For ALMIRALL SA (LBTSF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.